Details
This activity is supported by educational grants from Alcon Laboratories Inc., Allergan Inc., Bausch + Lomb, and Glaukos Corporation.
Credits: By completing this activity you will earn 1.0 AMA PRA Category 1 Credit™.
Activity Expiration Date: August 31, 2018
Course Objectives
Upon successful completion of this activity, participants should be able to:
- Identify the diagnostic protocols necessary to evaluate fluid drainage and optic nerve structure and function to guide glaucoma therapy decisions
- Analyze the risks and benefits of combination therapy
Describe how and when to integrate new MIGS options from early to advanced glaucoma